
The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve
Global Business Development (GBD) contributes to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists–looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo.
The search for novel therapeutics focuses on diabetes, obesity, liver and CVD, blood & endocrine disorders as well as Consumer Rx. Besides our therapeutic areas of interest, SE&I supports the identification of cutting-edge enabling technologies across several modalities. Working cross-functionally, SE&I supports the assessment of such external opportunities all the way through due diligence and contractual negotiation, and this role is directly responsible for cross-functionally leading evaluations of BD opportunities from initial evaluation through due diligence.
The position is part of the global SE&I evaluation team with members located predominantly in Denmark and Cambridge, MA, US. Reports to the Head of Global Evaluation. The role will interact cross-functionally with stakeholders from the entire value chain while working in close collaboration with Novo’s Business Development teams located in Denmark and Cambridge. This position will also leverage their networks and actively engage with external stakeholders including biotech companies, venture capital firms and large-cap pharma communities. The role has no direct or indirect reports.
10-20% overnight travel required; May require international travel.
The base compensation range for this position is $187,100 to $327,500. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy and parental leave policy.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.
Novo is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html